Wang, Zhao

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., Wang, L., et al. (2020) · The Lancet

SARS-CoV-2 and COVID-19 ResearchVirus-based gene therapy research

Cited by 1,382

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., et al. (2020) · The Lancet

SARS-CoV-2 and COVID-19 ResearchVirus-based gene therapy research

Cited by 1,225

Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes

Yu, X., Yi, P., Hamilton, R. A., Shen, H., Chen, M., Foulds, C. E., Mancini, M. A., Ludtke, S. J., Wang, Z., & O’Malley, B. W. (2020) · Molecular Cell

Prostate Cancer Treatment and ResearchEstrogen and related hormone effects

Cited by 154

The identification of XPR1 as a voltage- and phosphate-activated phosphate-permeable ion channel

Wu, H., Sun, L., Huo, T., Wensel, T. G., Horrigan, F. T., & Wang, Z. (2025) · Nature Communications

Ion channel regulation and functionIon Transport and Channel Regulation

Cited by 8